Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Nasdaq: AGIO
    
Event Details

Q1 2017 Agios Pharmaceuticals Inc Earnings Conference Call

Thursday, May 4, 2017 8:00 a.m. ET  
Title
Q1 2017 Agios Pharmaceuticals Inc Earnings Conference Call
Date / Time
05/04/17 8:00 a.m. ET